mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0009 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.2 |
0.001 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.002 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |